211 related articles for article (PubMed ID: 19383899)
1. TGF-beta1 + EGF-initiated invasive potential in transformed human keratinocytes is coupled to a plasmin/MMP-10/MMP-1-dependent collagen remodeling axis: role for PAI-1.
Wilkins-Port CE; Ye Q; Mazurkiewicz JE; Higgins PJ
Cancer Res; 2009 May; 69(9):4081-91. PubMed ID: 19383899
[TBL] [Abstract][Full Text] [Related]
2. Regulation of extracellular matrix remodeling following transforming growth factor-beta1/epidermal growth factor-stimulated epithelial-mesenchymal transition in human premalignant keratinocytes.
Wilkins-Port CE; Higgins PJ
Cells Tissues Organs; 2007; 185(1-3):116-22. PubMed ID: 17587817
[TBL] [Abstract][Full Text] [Related]
3. PAI-1 mediates the TGF-beta1+EGF-induced "scatter" response in transformed human keratinocytes.
Freytag J; Wilkins-Port CE; Higgins CE; Higgins SP; Samarakoon R; Higgins PJ
J Invest Dermatol; 2010 Sep; 130(9):2179-90. PubMed ID: 20428185
[TBL] [Abstract][Full Text] [Related]
4. Upstream stimulatory factor regulates E box-dependent PAI-1 transcription in human epidermal keratinocytes.
Allen RR; Qi L; Higgins PJ
J Cell Physiol; 2005 Apr; 203(1):156-65. PubMed ID: 15372465
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase-1 and -9 activation by plasmin regulates a novel endothelial cell-mediated mechanism of collagen gel contraction and capillary tube regression in three-dimensional collagen matrices.
Davis GE; Pintar Allen KA; Salazar R; Maxwell SA
J Cell Sci; 2001 Mar; 114(Pt 5):917-30. PubMed ID: 11181175
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta1 inhibits tumor growth in a mouse melanoma model by down-regulating the plasminogen activation system.
Ramont L; Pasco S; Hornebeck W; Maquart FX; Monboisse JC
Exp Cell Res; 2003 Nov; 291(1):1-10. PubMed ID: 14597403
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta 1 promotes matrix metalloproteinase-9-mediated oral cancer invasion through snail expression.
Sun L; Diamond ME; Ottaviano AJ; Joseph MJ; Ananthanarayan V; Munshi HG
Mol Cancer Res; 2008 Jan; 6(1):10-20. PubMed ID: 18234959
[TBL] [Abstract][Full Text] [Related]
8. TGF-β1 Suppresses Plasmin and MMP Activity in Flexor Tendon Cells via PAI-1: Implications for Scarless Flexor Tendon Repair.
Farhat YM; Al-Maliki AA; Easa A; O'Keefe RJ; Schwarz EM; Awad HA
J Cell Physiol; 2015 Feb; 230(2):318-26. PubMed ID: 24962629
[TBL] [Abstract][Full Text] [Related]
9. Urokinase expression and binding activity associated with the transforming growth factor beta1-induced migratory and invasive phenotype of mouse epidermal keratinocytes.
Santibáñez JF; Frontelo P; Iglesias M; Martínez J; Quintanilla M
J Cell Biochem; 1999 Jul; 74(1):61-73. PubMed ID: 10381262
[TBL] [Abstract][Full Text] [Related]
10. Plasminogen activator inhibitor-1 gene deficiency attenuates TGF-beta1-induced kidney disease.
Krag S; Danielsen CC; Carmeliet P; Nyengaard J; Wogensen L
Kidney Int; 2005 Dec; 68(6):2651-66. PubMed ID: 16316341
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of membrane type 1-matrix metalloproteinase activity by ERK 1/2- and p38 MAPK-modulated tissue inhibitor of metalloproteinases 2 expression controls transforming growth factor-beta1-induced pericellular collagenolysis.
Munshi HG; Wu YI; Mukhopadhyay S; Ottaviano AJ; Sassano A; Koblinski JE; Platanias LC; Stack MS
J Biol Chem; 2004 Sep; 279(37):39042-50. PubMed ID: 15247230
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor and transforming growth factor-beta1 enhance HK-2 cell migration through a synergistic increase of matrix metalloproteinase and sustained activation of ERK signaling pathway.
Tian YC; Chen YC; Chang CT; Hung CC; Wu MS; Phillips A; Yang CW
Exp Cell Res; 2007 Jul; 313(11):2367-77. PubMed ID: 17467690
[TBL] [Abstract][Full Text] [Related]
13. Thrombospondin-1 and transforming growth factor beta-1 upregulate plasminogen activator inhibitor type 1 in pancreatic cancer.
Albo D; Berger DH; Vogel J; Tuszynski GP
J Gastrointest Surg; 1999; 3(4):411-7. PubMed ID: 10482694
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-β1 induces invasion ability of HSC-4 human oral squamous cell carcinoma cells through the Slug/Wnt-5b/MMP-10 signalling axis.
Hino M; Kamo M; Saito D; Kyakumoto S; Shibata T; Mizuki H; Ishisaki A
J Biochem; 2016 Jun; 159(6):631-40. PubMed ID: 26861993
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase-21 is expressed epithelially during development and in cancer and is up-regulated by transforming growth factor-beta1 in keratinocytes.
Ahokas K; Lohi J; Illman SA; Llano E; Elomaa O; Impola U; Karjalainen-Lindsberg ML; Saarialho-Kere U
Lab Invest; 2003 Dec; 83(12):1887-99. PubMed ID: 14691307
[TBL] [Abstract][Full Text] [Related]
16. ROS-NFkappaB mediates TGF-beta1-induced expression of urokinase-type plasminogen activator, matrix metalloproteinase-9 and cell invasion.
Tobar N; Villar V; Santibanez JF
Mol Cell Biochem; 2010 Jul; 340(1-2):195-202. PubMed ID: 20204677
[TBL] [Abstract][Full Text] [Related]
17. SKIP is required for TGF-β1-induced epithelial mesenchymal transition and migration in transformed keratinocytes.
Villar V; Kocic J; Bugarski D; Jovcic G; Santibanez JF
FEBS Lett; 2010 Nov; 584(22):4586-92. PubMed ID: 20965173
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activator inhibitor type-1 gene expression and induced migration in TGF-beta1-stimulated smooth muscle cells is pp60(c-src)/MEK-dependent.
Samarakoon R; Higgins CE; Higgins SP; Kutz SM; Higgins PJ
J Cell Physiol; 2005 Jul; 204(1):236-46. PubMed ID: 15622520
[TBL] [Abstract][Full Text] [Related]
19. Collagenase 3 (matrix metalloproteinase 13) gene expression by HaCaT keratinocytes is enhanced by tumor necrosis factor alpha and transforming growth factor beta.
Johansson N; Westermarck J; Leppä S; Häkkinen L; Koivisto L; López-Otín C; Peltonen J; Heino J; Kähäri VM
Cell Growth Differ; 1997 Feb; 8(2):243-50. PubMed ID: 9040946
[TBL] [Abstract][Full Text] [Related]
20. Progressive abrogation of TGF-beta 1 and EGF growth control is associated with tumour progression in ras-transfected human keratinocytes.
Game SM; Huelsen A; Patel V; Donnelly M; Yeudall WA; Stone A; Fusenig NE; Prime SS
Int J Cancer; 1992 Sep; 52(3):461-70. PubMed ID: 1328069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
